Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

DAWN Day One Biopharmaceuticals

Watchlist
21.110
-0.640-2.94%
Close  02/03 16:00 ET
21.150
+0.040+0.19%
Post Mkt Price 02/03 19:32 ET
High
21.975
Open
21.300
Turnover
9.26M
Low
20.920
Pre Close
21.750
Volume
434.25K
Market Cap
1.55B
P/E(TTM)
Loss
52wk High
28.350
Shares
73.55M
P/E(Static)
Loss
52wk Low
5.440
Float Cap
823.91M
Bid/Ask %
0.00%
Historical High
28.699
Shs Float
39.03M
Volume Ratio
0.92
Historical Low
5.440
Dividend TTM
--
Div Yield TTM
--
P/B
4.28
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.11%
Amplitude
4.85%
Avg Price
21.316
Lot Size
1
Float Cap
823.91M
Bid/Ask %
0.00%
Historical High
28.699
Shs Float
39.03M
Volume Ratio
0.92
Historical Low
5.440
Dividend TTM
--
P/B
4.28
Dividend LFY
--
Turnover Ratio
1.11%
Amplitude
4.85%
Avg Price
21.316
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in South San Francisco, CA.
CEO: Dr. Jeremy Bender
Market: NASDAQ
Listing Date: 05/27/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist